Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor

International Journal of Hematology

Volumn 92, Issue 5, 2010, Pages 765-768

  Nasilowska Adamska, B ^a   Perkowska Ptasinska, A ^b   Tomaszewska, A ^a   Serwacka, A ^c   Marianska, B ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Clinical Hospital   (Poland)

Author keywords

G CSF; Glomerulonephritis; Stem cells donor

Indexed keywords

AMGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ACUTE GLOMERULONEPHRITIS; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; DONOR; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; PROTEINURIA; STEM CELL MOBILIZATION; TREATMENT DURATION;

ACUTE DISEASE; ADULT; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; TISSUE DONORS;

EID: 78751573027     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0730-6     Document Type: Article

References (9)

1. G Favre M Beksac A Bacigalupo T Ruutu A Nagler E Gluckman, et al. 2003 Differences between graft product and donor side effects following bone marrow or stem cell donation Bone Marrow Transplant 32 873 880 1:CAS:528: DC%2BD3sXotFems7o%3D 14561987 10.1038/sj.bmt.1704245
2. CC Tigue JM McKoy AM Evens SM Trifilio MS Tallman CL Bennett 2007 Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety consideration from the Research on Adverse Drug Events and Reports Project Bone Marrow Transplant 40 185 192 1:CAS:528:DC%2BD2sXnvFaqt70%3D 17563736 10.1038/sj.bmt.1705722
3. JP Miller EH Perry TH Price CD Bolan Jr C Karanes TM Boyd, et al. 2008 Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program Biol Blood Marrow Transplant 14 29 36 18721778 10.1016/j.bbmt.2008.05.018
4. J Halter Y Kodera AU Ispizua HT Greinix N Schmitz G Favre, et al. 2009 (EBMT) Severe events in donors after allogeneic hematopoietic stem cell donation Haematologica 94 94 101 19059940 10.3324/haematol.13668
5. M Sotomatsu T Kanazawa C Ogawa T Watanabe A Morikawa 2000 Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim) Br J Haematol 110 234 235 1:STN:280:DC%2BD3cvisVKitg%3D%3D 10931006 10.1046/j.1365-2141.2000. 02072-1.x
6. DC Dale TE Ottle CJ Fier AA Bolyard MA Bonilla LA Boxer, et al. 2003 Severe Chronic neutropenia: treatment and follow up of patients in the Severe Chronic Neutropenia International Registry Am J Hematol 72 82 93 12555210 10.1002/ajh.10255
7. N Kröger Ar Zander 2002 Dose and schedule effect of G-CSF for stem cell mobilization in healthy donors for allogeneic transplantation Leuk Lymphoma 43 7 1391 1394 12389618 10.1080/10428190290033323
8. A Falanga M Marchetti V Evangelista S Manarini E Oldani S Giovanelli, et al. 1999 Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor Blood 93 2506 2514 1:CAS:528:DyaK1MXisVGktrY%3D 10194429
9. P Anderlini RE Champlin 2008 Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges Blood 111 1767 1772 1:CAS:528:DC%2BD1cXisVCktbg%3D 18057230 10.1182/blood-2007-07-097543